##ANALYSISTYPE=SOMATIC_PAIR
##PIPELINE=megSAP 2022_08-92-g2d1638ba
##GENOME_BUILD=GRCh38
##CREATION_DATE=2022-02-10
##FILTER=all-unknown=Allele unknown
##FILTER=depth-tum=Sequencing depth in tumor is too low (< 20)
##FILTER=LowDepth=Tumor or normal sample read depth at this locus is below 2
##FILTER=LowEVS=Somatic Empirical Variant Score (SomaticEVS) is below threshold
##FILTER=lt-3-reads=Less than 3 supporting tumor reads
##FILTER=special-chromosome=Special chromosome
##DESCRIPTION=filter=Annotations for filtering and ranking variants.
##DESCRIPTION=quality=Quality parameters - variant quality (QUAL), depth (DP), quality divided by depth (QD), allele frequency (AF), mean mapping quality of alternate allele (MQM), probability of strand bias for alternate bases as phred score (SAP), probability of allele ballance as phred score (ABP)
##DESCRIPTION=gene=Affected gene list (comma-separated).
##DESCRIPTION=variant_type=Variant type.
##DESCRIPTION=coding_and_splicing=Coding and splicing details (Gene, ENST number, type, impact, exon/intron number, HGVS.c, HGVS.p, Pfam domain).
##DESCRIPTION=regulatory=Regulatory consequence details.
##DESCRIPTION=OMIM=OMIM database annotation.
##DESCRIPTION=ClinVar=ClinVar database annotation.
##DESCRIPTION=HGMD=HGMD database annotation.
##DESCRIPTION=RepeatMasker=RepeatMasker annotation.
##DESCRIPTION=dbSNP=Identifier in dbSNP database.
##DESCRIPTION=gnomAD=Allele frequency in gnomAD project.
##DESCRIPTION=gnomAD_sub=Sub-population allele frequenciens (AFR,AMR,EAS,NFE,SAS) in gnomAD project.
##DESCRIPTION=gnomAD_hom_hemi=Homoyzgous counts and hemizygous counts of gnomAD project (genome data).
##DESCRIPTION=gnomAD_het=Heterozygous counts of the gnomAD project (genome data).
##DESCRIPTION=gnomAD_wt=Wildtype counts of the gnomAD project (genome data).
##DESCRIPTION=phyloP=phyloP (100way vertebrate) annotation. Deleterious threshold > 1.6.
##DESCRIPTION=Sift=Sift effect prediction and score for each transcript: D=damaging, T=tolerated.
##DESCRIPTION=PolyPhen=PolyPhen (humVar) effect prediction and score for each transcript: D=probably damaging, P=possibly damaging, B=benign.
##DESCRIPTION=CADD=CADD pathogenicity prediction scores (scaled phred-like). Deleterious threshold > 10-20.
##DESCRIPTION=REVEL=REVEL pathogenicity prediction score. Deleterious threshold > 0.5.
##DESCRIPTION=MaxEntScan=MaxEntScan splicing prediction (reference bases score/alternate bases score).
##DESCRIPTION=COSMIC=COSMIC somatic variant database anntotation.
##DESCRIPTION=SpliceAI=SpliceAI prediction of splice-site variations. Probability of the variant being splice-altering (range from 0-1). The score is the maximum value of acceptor/donor gain/loss of all effected genes.
##DESCRIPTION=PubMed=PubMed ids to publications on the given variant.
##DESCRIPTION=NGSD_som_c=Somatic variant count in the NGSD.
##DESCRIPTION=NGSD_som_p=Project names of project containing this somatic variant in the NGSD.
##DESCRIPTION=NGSD_som_vicc_interpretation=Somatic variant interpretation according VICC standard in the NGSD.
##DESCRIPTION=NGSD_som_vicc_comment=Somatic VICC interpretation comment in the NGSD.
##DESCRIPTION=NGSD_hom=Homozygous variant count in NGSD.
##DESCRIPTION=NGSD_het=Heterozygous variant count in NGSD.
##DESCRIPTION=NGSD_group=Homozygous / heterozygous variant count in NGSD with the same disease group.
##DESCRIPTION=classification=Classification from the NGSD.
##DESCRIPTION=classification_comment=Classification comment from the NGSD.
##DESCRIPTION=validation=Validation information from the NGSD. Validation results of other samples are listed in brackets!
##DESCRIPTION=comment=Variant comments from the NGSD.
##DESCRIPTION=gene_info=Gene information from NGSD (inheritance mode, gnomAD o/e scores).
##FILTER=low_conf_region=Low confidence region for small variant calling based on gnomAD AC0/RF filters and IMGAG trio/twin data.
##DESCRIPTION=tumor_af=Mutant allele frequency in tumor (Sample DX000001_01).
##DESCRIPTION=tumor_dp=Tumor Depth (Sample DX000001_01).
##DESCRIPTION=normal_af=Mutant allele frequency in normal (Sample DX000002_01).
##DESCRIPTION=normal_dp=Normal depth (Sample DX000002_01).
##DESCRIPTION=somatic_classification_comment=Somatic classification comment from the NGSD.
##DESCRIPTION=somatic_classification=Somatic classification from the NGSD.
#chr	start	end	ref	obs	tumor_af	tumor_dp	normal_af	normal_dp	filter	quality	gene	variant_type	coding_and_splicing	regulatory	OMIM	ClinVar	HGMD	RepeatMasker	dbSNP	gnomAD	gnomAD_sub	gnomAD_hom_hemi	gnomAD_het	gnomAD_wt	phyloP	Sift	PolyPhen	CADD	REVEL	MaxEntScan	COSMIC	SpliceAI	PubMed	NGSD_som_c	NGSD_som_p	NGSD_som_vicc_interpretation	NGSD_som_vicc_comment	NGSD_hom	NGSD_het	NGSD_group	classification	classification_comment	somatic_classification	somatic_classification_comment	validation	comment	gene_info
chr9	21970976	21970979	CGTG	-	0.5695	1531	0.0000	846		QUAL=2237	CDKN2A,RP11-145E5.5	frameshift,3'UTR,intron&NMD_transcript,splice_region&3'UTR,frameshift&splice_region	CDKN2A:ENST00000304494.5:frameshift_variant:HIGH:exon2/3:c.380_383del:p.Ala127GlyfsTer18:PF12796 [Ankyrin repeats (3 copies)],CDKN2A:ENST00000361570.3:3_prime_UTR_variant:MODIFIER:exon2/3:c.*24_*27del::,RP11-145E5.5:ENST00000404796.2:intron_variant&NMD_transcript_variant:MODIFIER:intron4/5:c.348-58455_348-58452del::,CDKN2A:ENST00000446177.1:frameshift_variant:HIGH:exon2/3:c.380_383del:p.Ala127GlyfsTer18:PF12796 [Ankyrin repeats (3 copies)],CDKN2A:ENST00000479692.2:frameshift_variant:HIGH:exon2/3:c.227_230del:p.Ala76GlyfsTer18:PF12796 [Ankyrin repeats (3 copies)],CDKN2A:ENST00000494262.1:frameshift_variant:HIGH:exon3/4:c.227_230del:p.Ala76GlyfsTer18:PF12796 [Ankyrin repeats (3 copies)],CDKN2A:ENST00000497750.1:frameshift_variant:HIGH:exon2/2:c.227_230del:p.Ala76GlyfsTer18:PF12796 [Ankyrin repeats (3 copies)],CDKN2A:ENST00000498124.1:frameshift_variant:HIGH:exon2/4:c.380_383del:p.Ala127GlyfsTer18:PF12796 [Ankyrin repeats (3 copies)],CDKN2A:ENST00000498628.2:frameshift_variant:HIGH:exon2/3:c.227_230del:p.Ala76GlyfsTer18:PF12796 [Ankyrin repeats (3 copies)],CDKN2A:ENST00000530628.2:splice_region_variant&3_prime_UTR_variant:LOW:exon2/3:c.*24_*27del::,CDKN2A:ENST00000578845.2:frameshift_variant:HIGH:exon1/2:c.227_230del:p.Ala76GlyfsTer18:PF12796 [Ankyrin repeats (3 copies)],CDKN2A:ENST00000579122.1:frameshift_variant&splice_region_variant:HIGH:exon2/3:c.380_383del:p.Ala127AspfsTer5:,CDKN2A:ENST00000579755.1:3_prime_UTR_variant:MODIFIER:exon2/3:c.*24_*27del::												-0.2320									1	SomaticAndTreatment	LIKELY_ONCOGENIC	test comment	0	0	0 / 0							CDKN2A-DT (inh=n/a oe_syn=0.99 oe_mis=0.75 oe_lof=n/a):CDKN2A (inh=AD oe_syn=1.09 oe_mis=1.28 oe_lof=0.20)
chr11	64118936	64118936	A	C	0.4436	657	0.0000	183		QUAL=437	FLRT1,MACROD1,RP11-21A7A.3	3'UTR,intron,intron&non_coding_transcript	FLRT1:ENST00000246841.3:3_prime_UTR_variant:MODIFIER:exon2/2:c.*644A>C::,MACROD1:ENST00000255681.6:intron_variant:MODIFIER:intron3/10:c.517+32303T>G::,RP11-21A7A.3:ENST00000543817.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.70-159T>G::						rs371030473	0.0001		0,.			-1.5880			2.55						0				0	0	0 / 0							MACROD1 (inh=n/a oe_syn=1.24 oe_mis=0.82 oe_lof=0.19):FLRT1 (inh=n/a oe_syn=0.95 oe_mis=0.80 oe_lof=0.23)
chr12	4370550	4370550	G	A	0.2260	981	0.0000	431		QUAL=440	FGF23	synonymous	FGF23:ENST00000237837.1:synonymous_variant:LOW:exon3/3:c.549C>T:p.Asp183=:						rs369808475	0.0001		0,.			-0.0050			0.13						0				0	0	0 / 0							FGF23 (inh=AR+AD oe_syn=0.78 oe_mis=0.91 oe_lof=0.50)
chr12	25245350	25245350	C	A	0.4521	2054	0.0000	793		QUAL=1725	KRAS	missense	KRAS:ENST00000256078.4:missense_variant:MODERATE:exon2/6:c.35G>T:p.Gly12Val:PF00071 [Ras family],KRAS:ENST00000311936.3:missense_variant:MODERATE:exon2/5:c.35G>T:p.Gly12Val:PF00071 [Ras family],KRAS:ENST00000556131.1:missense_variant:MODERATE:exon2/3:c.35G>T:p.Gly12Val:PF00071 [Ras family],KRAS:ENST00000557334.1:missense_variant:MODERATE:exon2/3:c.35G>T:p.Gly12Val:PF00071 [Ras family]			12583 [pathogenic DISEASE=Cerebral arteriovenous malformation,Acute myeloid leukemia,Nevus sebaceous,Juvenile myelomonocytic leukemia,Non-small cell lung cancer,Neoplasm of the thyroid gland,Neoplasm of the large intestine,Carcinoma of pancreas,Ovarian Neoplasms,not provided];	CM125165 [CLASS=R MUT=ALT PHEN="Colorectal cancer" GENE=KRAS];		rs121913529						7.8920	D(0.00),D(0.00),D(0.00),D(0.00)	D(0.97),D(0.96),P(0.88),D(0.98)	27.00	0.91		COSV55497369,COSV55497419,COSV55497479			45	ARO-16,I18D033_ssSC,PATHO_Somatic,SomaticAndTreatment	LIKELY_ONCOGENIC	test likely oncogenic variant	0	0	0 / 0							KRAS (inh=AR+AD oe_syn=0.93 oe_mis=0.34 oe_lof=0.63)
chr14	21428080	21428080	T	A	0.2404	2290	0.0000	864		QUAL=932	CHD8	missense	CHD8:ENST00000399982.2:missense_variant:MODERATE:exon3/37:c.1390A>T:p.Ile464Phe:,CHD8:ENST00000430710.3:missense_variant:MODERATE:exon4/38:c.553A>T:p.Ile185Phe:,CHD8:ENST00000557364.1:missense_variant:MODERATE:exon4/38:c.1390A>T:p.Ile464Phe:												7.2180	D(0.00),D(0.00),D(0.00)	D(0.99),D(1.00),D(0.99)	26.90	0.18					1	SomaticAndTreatment	UNCERTAIN_SIGNIFICANCE	some random comment by ahmustm1	0	0	0 / 0							CHD8 (inh=AD oe_syn=0.94 oe_mis=0.56 oe_lof=0.04):RN7SL650P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr15	87983579	87983579	A	C	0.3192	1249	0.0000	572		QUAL=815	NTRK3	intron	NTRK3:ENST00000317501.3:intron_variant:MODIFIER:intron13/14:c.1586-2219T>G::,NTRK3:ENST00000355254.2:intron_variant:MODIFIER:intron13/17:c.1586-42826T>G::,NTRK3:ENST00000357724.2:intron_variant:MODIFIER:intron12/17:c.1562-42826T>G::,NTRK3:ENST00000360948.2:intron_variant:MODIFIER:intron13/18:c.1586-42826T>G::,NTRK3:ENST00000394480.2:intron_variant:MODIFIER:intron14/18:c.1586-42826T>G::,NTRK3:ENST00000540489.2:intron_variant:MODIFIER:intron12/13:c.1586-2219T>G::,NTRK3:ENST00000542733.2:intron_variant:MODIFIER:intron12/15:c.1292-42826T>G::,NTRK3:ENST00000557856.1:intron_variant:MODIFIER:intron11/15:c.1562-42826T>G::,NTRK3:ENST00000558676.1:intron_variant:MODIFIER:intron11/13:c.1562-42826T>G::												0.8150			4.44						0				0	0	0 / 0							NTRK3 (inh=AD oe_syn=1.20 oe_mis=0.77 oe_lof=0.12)
chr15	88013500	88013500	G	T	0.5822	881	0.0000	414		QUAL=1221	NTRK3	intron	NTRK3:ENST00000317501.3:intron_variant:MODIFIER:intron13/14:c.1585+19357C>A::,NTRK3:ENST00000355254.2:intron_variant:MODIFIER:intron13/17:c.1585+19357C>A::,NTRK3:ENST00000357724.2:intron_variant:MODIFIER:intron12/17:c.1561+19357C>A::,NTRK3:ENST00000360948.2:intron_variant:MODIFIER:intron13/18:c.1585+19357C>A::,NTRK3:ENST00000394480.2:intron_variant:MODIFIER:intron14/18:c.1585+19357C>A::,NTRK3:ENST00000540489.2:intron_variant:MODIFIER:intron12/13:c.1585+19357C>A::,NTRK3:ENST00000542733.2:intron_variant:MODIFIER:intron12/15:c.1291+19357C>A::,NTRK3:ENST00000557856.1:intron_variant:MODIFIER:intron11/15:c.1561+19357C>A::,NTRK3:ENST00000558676.1:intron_variant:MODIFIER:intron11/13:c.1561+19357C>A::												0.7020			12.88						0				0	0	0 / 0							NTRK3 (inh=AD oe_syn=1.20 oe_mis=0.77 oe_lof=0.12)
chr16	72793431	72793431	A	T	0.3223	2042	0.0000	1054		QUAL=1424	ZFHX3	missense	ZFHX3:ENST00000268489.5:missense_variant:MODERATE:exon9/10:c.9251T>A:p.Ile3084Asn:,ZFHX3:ENST00000397992.5:missense_variant:MODERATE:exon8/9:c.6509T>A:p.Ile2170Asn:												9.3250	D(0.00),D(0.00)	D(1.00),D(1.00)	28.70	0.70					0				0	0	0 / 0							ZFHX3 (inh=AD oe_syn=1.04 oe_mis=0.91 oe_lof=0.18)
chr17	7674229	7674229	C	A	0.6279	3114	0.0019	2151		QUAL=3070	TP53	missense	TP53:ENST00000269305.4:missense_variant:MODERATE:exon7/11:c.734G>T:p.Gly245Val:PF00870 [P53 DNA-binding domain],TP53:ENST00000359597.4:missense_variant:MODERATE:exon6/9:c.734G>T:p.Gly245Val:PF00870 [P53 DNA-binding domain],TP53:ENST00000413465.2:missense_variant:MODERATE:exon6/7:c.734G>T:p.Gly245Val:PF00870 [P53 DNA-binding domain],TP53:ENST00000420246.2:missense_variant:MODERATE:exon7/12:c.734G>T:p.Gly245Val:PF00870 [P53 DNA-binding domain],TP53:ENST00000445888.2:missense_variant:MODERATE:exon7/11:c.734G>T:p.Gly245Val:PF00870 [P53 DNA-binding domain],TP53:ENST00000455263.2:missense_variant:MODERATE:exon7/12:c.734G>T:p.Gly245Val:PF00870 [P53 DNA-binding domain]			376603 [pathogenic/likely pathogenic DISEASE=Hepatocellular carcinoma,Pancreatic adenocarcinoma,Transitional cell carcinoma of the bladder,Brainstem glioma,Carcinoma of esophagus,Lung adenocarcinoma,Squamous cell lung carcinoma,Neoplasm of brain,Neoplasm of the breast,Neoplasm of the large intestine,Squamous cell carcinoma of the head and neck,Glioblastoma,Adenocarcinoma of prostate,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Adenocarcinoma of stomach,Ovarian Serous Cystadenocarcinoma,Uterine Carcinosarcoma];	CM010464 [CLASS=DM MUT=ALT PHEN="Lung cancer" GENE=TP53];		rs121912656						7.9050	D(0.00),D(0.00),D(0.00),D(0.00),D(0.00),D(0.00)	D(1.00),D(1.00),D(1.00),D(1.00),D(1.00),D(1.00)	27.60	0.97		COSV52666323,COSV52667838,COSV52745465		87654321	1	SomaticAndTreatment	ONCOGENIC	test comment for oncogenic variant	0	0	0 / 0							TP53 (inh=AR+AD oe_syn=1.07 oe_mis=0.82 oe_lof=0.20)
chrX	53380683	53380683	G	A	0.2090	1811	0.0000	711		QUAL=641	SMC1A	synonymous	SMC1A:ENST00000322213.4:synonymous_variant:LOW:exon24/25:c.3555C>T:p.Ile1185=:PF02463 [RecF/RecN/SMC N terminal domain]												-1.8910			9.86						0				0	0	0 / 0							SMC1A (inh=XLR+XLD oe_syn=0.98 oe_mis=0.20 oe_lof=0.00)
chrX	67545174	67545174	G	T	0.4085	1320	0.0000	376		QUAL=782	AR	missense	AR:ENST00000374690.3:missense_variant:MODERATE:exon1/8:c.28G>T:p.Val10Phe:PF02166 [Androgen receptor],AR:ENST00000396044.3:missense_variant:MODERATE:exon1/5:c.28G>T:p.Val10Phe:PF02166 [Androgen receptor],AR:ENST00000504326.1:missense_variant:MODERATE:exon1/4:c.28G>T:p.Val10Phe:PF02166 [Androgen receptor]	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site											2.6220	D(0.00),D(0.00),D(0.00)	P(0.47),P(0.47),P(0.69)	24.80	0.79					0				0	0	0 / 0							AR (inh=XLR oe_syn=1.09 oe_mis=0.82 oe_lof=0.11)
chrX	71130104	71130104	A	T	0.1432	2906	0.0000	778		QUAL=516	MED12	missense	MED12:ENST00000333646.6:missense_variant:MODERATE:exon28/45:c.3937A>T:p.Ser1313Cys:,MED12:ENST00000374080.3:missense_variant:MODERATE:exon28/45:c.3937A>T:p.Ser1313Cys:,MED12:ENST00000374102.1:missense_variant:MODERATE:exon28/45:c.3937A>T:p.Ser1313Cys:												3.5960	D(0.00),D(0.00),D(0.00)	P(0.72),P(0.76),P(0.88)	25.20	0.45					1	SomaticAndTreatment	UNCERTAIN_SIGNIFICANCE	test comment for uncertain significant variant.  This comment includes äöüß  and newlines and  tabs and other special '\/()&!"§$%%&/()=?`characters	0	0	0 / 0							MED12 (inh=XLR oe_syn=0.91 oe_mis=0.38 oe_lof=0.02)
chrX	111220455	111220455	A	T	0.1546	791	0.0000	223		QUAL=203	PAK3	3'UTR	PAK3:ENST00000262836.4:3_prime_UTR_variant:MODIFIER:exon15/15:c.*8A>T::,PAK3:ENST00000360648.4:3_prime_UTR_variant:MODIFIER:exon16/16:c.*8A>T::,PAK3:ENST00000372007.5:3_prime_UTR_variant:MODIFIER:exon18/18:c.*8A>T::,PAK3:ENST00000372010.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*8A>T::,PAK3:ENST00000417227.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*8A>T::,PAK3:ENST00000425146.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*8A>T::,PAK3:ENST00000446737.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*8A>T::,PAK3:ENST00000519681.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*8A>T::												0.3850			12.99						0				0	0	0 / 0							PAK3 (inh=XLR oe_syn=0.95 oe_mis=0.32 oe_lof=0.09)
